Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898430-97-002215
Filing Date
1997-05-16
Accepted
1997-05-16 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 19576
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1350
3 TRANSACTION BY REPORTING PERSONS DURING THE LAST 60 DAYS EX-99.B 6654
  Complete submission text file 0000898430-97-002215.txt   29843
Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44877 | Film No.: 97610726
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice